We urge you to utilize analysis of DarioHealth Corp fundamentals to see if markets are presently mispricing the company. We found thirty-four available fundamental indicators for DarioHealth Corp which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all DarioHealth Corp fundamentals including its Price to Sales, Cash Flow from Operations, Current Liabilities, as well as the relationship between Cash and Equivalents and Market Capitalization . Please also check DarioHealth Corp Number of Shares Shorted to verify the company can sustain itself down the road.Use DarioHealth Corp to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of DarioHealth Corp to be traded at $1.8875 in 30 days
DarioHealth Corp Company SummaryDarioHealth Corp competes with Edwards Lifesciences, EndoChoice Holdings, Vascular Solutions, Digirad, and LABSTYLE. DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The company was founded in 2011 and is headquartered in Caesarea, Israel. DarioHealth Corp operates under Medical Laboratories Research classification in USA and traded on Nasdaq Capital Markets exchange. It employs 30 people.
DarioHealth Corp EBITDA vs Z Score
DarioHealth Corp is rated # 5 in ebitda category among related companies. It is rated # 5 in z score category among related companies .